Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,574.80
(
-0.62%
)
Dow Jones
46,021.43
(
0.00%
)
Brent Oil
104.67
(
0.23%
)
Bitcoin
70,561.99
(
0.95%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: RockRat post# 92764

Friday, 03/19/2010 5:41:39 PM

Friday, March 19, 2010 5:41:39 PM

Post# of 257262
OSIP: I don’t think today’s CHMP ruling on NSCLC maintenance therapy warrants any material “pot sweetening” by Astellas. CHMP rulings tend to be leaky, and hence Astellas has probably known the likely outcome of this application for a while. Moreover, reimbursement by the individual EU countries for the new maintenance indication could be problematic, IMO.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now